0
The FDA has approved the manufacture and marketing of gabapentin tablets 600 and 800 mg (Ranbaxy). The tablets are the generic version of Pfizer’s Neurontin tablets.
Gabapentin canadian is indicated for the management of postherpetic neuralgia in adults and as adjunctive therapy for partial seizures in patients with epilepsy.
